High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations

This publication has 18 references indexed in Scilit:

• Investigation of the neuroleptic drug haloperidol and its metabolites using tandem mass spectrometry
  International Journal of Mass Spectrometry and Ion Processes, 1992
• Simultaneous determination of haloperidol and its metabolite, reduced haloperidol, in plasma, blood, urine and tissue homogenates by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1991
• Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite
  Toxicology Letters, 1991
• Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite
  Chemical Research in Toxicology, 1991
• High-performance liquid chromatographic analysis of haloperidol and hydroxyhaloperidol in plasma after solid-phase extraction
  Journal of Chromatography B: Biomedical Sciences and Applications, 1990
• Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats
  Biochemical and Biophysical Research Communications, 1990
• Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+
  Chemical Research in Toxicology, 1988
• Measurement of haloperidol and reduced haloperidol in human plasma using réversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1986
• High-performance liquid chromatography of haloperidol in serum at the concentrations achieved during chronic therapy
  Journal of Chromatography B: Biomedical Sciences and Applications, 1984
• Distribution, excretion and metabolism of neuroleptics of the butyrophenone type: Part I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat
  European Journal of Pharmacology, 1967